Investigating the role of tumor cell heterogeneity and angiogenesis genes in the prognosis of multiple myeloma

QR Code

Investigating the role of tumor cell heterogeneity and angiogenesis genes in the prognosis of multiple myeloma

BackgroundMultiple myeloma (MM) is a common hematologic malignancy characterized by high tumor cell heterogeneity, which significantly impacts the clinical prognosis of patients. Angiogenesis and the molecular features of tumor cells play a critical role in tumor progression and drug resistance. Thi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xue Qiao, Zhengrong Song, Li Geng, Lina Xing, Ying Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Immunology
Subjects:	multiple myeloma tumor cell heterogeneity angiogenesis genes prognostic model single -cell analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1610833/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CHARACTERISTICS OF BONE MARROW MICROENVIRONMENT IN MULTIPLE MYELOMA BEFORE AND AFTER TREATMENT
by: V. I. Rugal, et al.
Published: (2019-03-01)

Nestin in multiple myeloma: emerging insights into a potential therapeutic target
by: Yingmiao Wu, et al.
Published: (2025-07-01)

Multiple myeloma and cardiovascular risk (a literature review)
by: B. B. Samura, et al.
Published: (2020-11-01)

Cardiovascular events after polychemotherapy of multiple myeloma: modern ways to diagnostics
by: B. B. Samura, et al.
Published: (2020-03-01)

Construction and validation of a prognostic model based on cuproptosis-related genes in patients with multiple myeloma
by: KANG Zhongmin, et al.
Published: (2025-07-01)

Prognostic Significance of Neutrophil to Lymphocyte Ratio in Multiple Myeloma Patient
by: Daniela DIACONESCU, et al.
Published: (2025-06-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

MASS-4 is more suitable than MASS-3 for prognostic stratification in transplant-eligible patients with newly diagnosed multiple myeloma
by: Fan Yang, et al.
Published: (2025-12-01)

Creation of a collection of blood samples of patients with multiple myeloma
by: N. V. Gnennaya, et al.
Published: (2022-01-01)

IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
by: E. A. Senkina, et al.
Published: (2014-07-01)

Deciphering the bone marrow microenvironment’s role in multiple myeloma immunotherapy resistance
by: Nicolas Thomas Iannozzi, et al.
Published: (2025-07-01)

Identification and validation of the m6A-binding protein LRPPRC to promote tumorigenesis in multiple myeloma
by: Jiaxin Tang, et al.
Published: (2025-12-01)

THE NEW DIAGNOSTIC FEATURES OF CD138 (SYNDECAN-1) IN MULTIPLE MYELOMA
by: A. F. Karamysheva
Published: (2015-12-01)

The multicenter experience with bendamustine in the treatment of relapsed and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2015-10-01)

DIAGNOSTIC OF NONSECRETORY MULTIPLE MYELOMA (CLINICAL CASE)
by: N. T. Vatutin, et al.
Published: (2017-03-01)

Prognosis of multiple myeloma patients based on histopathological evaluation of bone marrow
by: Niloofar Arefi Sigaroudi, et al.
Published: (2025-06-01)

Altered dynamics of T cell subsets in peripheral blood impacts disease progression in newly diagnosed multiple myeloma
by: Mohini Vig, et al.
Published: (2025-09-01)

The role of pomalidomide in treatment of relapse and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2022-01-01)

Pitfalls in the pathological diagnosis of multiple myeloma
by: V. V. Baykov
Published: (2022-11-01)

Value of P-selectin in the prognosis of cardiovascular events in patients with multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-08-01)

Stage-specific gene pair ratios highlight genes and mechanisms related to presymptomatic and symptomatic Multiple Myeloma
by: Grigoris Georgiou, et al.
Published: (2025-01-01)

Bortezomib-based Chemotherapy and Bone-marrow Followed by Renal Transplantation in Multiple Myeloma: A Literature Review
by: Jasmine Sethi, et al.
Published: (2025-04-01)

Immunophenotypic characteristics and prognostic value of peripheral blood circulating plasma cells in patients with newly diagnosed multiple myeloma
by: Chen Hong, et al.
Published: (2025-01-01)

Whole-body low-dose computed tomography in primary patients with multiple myeloma
by: A. M. Danilina, et al.
Published: (2023-05-01)

The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients
by: S. V. Voloshin, et al.
Published: (2022-04-01)

Expression of checkpoint molecules by regulatory T cells in multiple myeloma
by: A. A. Ostanin, et al.
Published: (2024-09-01)

Bone marrow MRI after autologous transplantation and the effect of residual tumor on progression-free survival of multiple myeloma patients
by: M. V. Solovev, et al.
Published: (2019-01-01)

Case report: pomalidomide as maintenance after salvage autologous stem cell transplantation in a patient with relapsed multiple myeloma
by: S. V. Semochkin, et al.
Published: (2023-12-01)

Neutrophilic hyperleukocytosis in the multiple myeloma onset
by: I. G. Rekhtina, et al.
Published: (2022-07-01)

Cariohemodynamics in patients with multiple myeloma depending on renal function
by: B. B. Samura, et al.
Published: (2019-12-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Minimising Toxicity and Maximising Response: T-Cell Engagers for Elderly Patients with Multiple Myeloma
by: Anthony McLoughlin, et al.
Published: (2025-06-01)

Attempt to assess direct interactions between tumor burden, myeloid-derived suppressor cells and PD-1- and TIM-3-expressing T cells in multiple myeloma patients
by: E. V. Batorov, et al.
Published: (2023-06-01)

Non-secretory myeloma: clinical profile and diagnostic utility of immunohistochemistry and free light chain assay in a rare variant of plasma cell myeloma
by: Monal Trisal, et al.
Published: (2025-04-01)

Role of high-dose chemotherapy with hemopoietic stem cell transplantation in the treatment of multiple myeloma
by: S. V. Minenko, et al.
Published: (2022-11-01)

Infectious complications in patients with multiple myeloma on first chemotherapy cycle
by: A. A. Novikova, et al.
Published: (2018-10-01)

Efficiency of pomalidomide therapy in patients with multiple myeloma refractory to lenalidomide
by: I. G. Rekhtina, et al.
Published: (2019-04-01)

Combination of multiple myeloma and chronic idiopathic myelofibrosis: a case report
by: N. A. Romanenko, et al.
Published: (2022-11-01)

Pharmacokinetics and outcome of high-dose melphalan followed by autologous stem cell transplantation in dialysis-dependent patients with multiple myeloma
by: Rabea Mecklenbrauck, et al.
Published: (2025-01-01)

Onset of multiple myeloma with rheumatic polymyalgia
by: E. R. Israelyan, et al.
Published: (2019-12-01)